Areas of Expertise

Dr Bates treats a range of conditions, including:

• Thyroid disease
• Overactive thyroid disorders
• Hyper and hypothyroidism
• Osteoporosis
• Calcium disorders
• Parathyroid disease
• Bone disease
• Pituitary disease
• Hirsutism
• PCOS
• Diabetes Mellitus
• Hormone tests

About Dr Andrew Bates

Dr Andrew Bates currently a busy full-time Consultant Endocrinologist/Diabetologist. He has a strong interest in all of the main areas of endocrinology and diabetes and has built up considerable experience over 21+ years as a consultant.

He is an expert in thyroid (ARSAC license holder enabling direct access to radioiodine for patients with overactive thyroid glands), pituitary, metabolic bone (osteoporosis, vitamin D deficiency, hyperparathyroidism), reproductive endocrinology (polycystic ovary syndrome, hirsutism, prolactin disorders), and general endocrinology (Addison’s disease, adrenal disorders, gynaecomastia, disorders of testosterone secretion).

Dr Bates continues to publish research in respected peer-reviewed journals, most recently relating to unusual causes of adrenal insufficiency and the impact of ethnicity on testosterone replacement therapy.

Dr Andrew Bates’ medical education was at Leeds University Medical School. He qualified in 1987 with Distinction in Microbiology. He obtained an additional degree, BSc (Hons), in Chemical Pathology, during the course of my medical studies. His postgraduate experience and training was obtained in West Yorkshire and the Midlands. Dr Bates has been fortunate in training under the supervision of many very eminent endocrinologists in the past, both in Birmingham and beyond. He obtained membership of the Royal College of Physicians at the first attempt in 1990.

Dr Bates was awarded a Sheldon Research Fellowship following a competitive selection process, to fund a period of three years of research under the supervision of Professor RN Clayton, which culminated in the award of his MD thesis in 1997 (Molecular genetics and epidemiology of pituitary tumours).

His professional qualifications include a BSc (Hons) in chemical pathology, MBChB, MD and FRCP (UK). He became a Fellow of the Royal College of Physicians in 2003 and is also a member of the Society for Endocrinology, European Society of Endocrinology, Endocrine Society (USA) and Diabetes UK.  On the 1st December 1997, he was appointed as a Consultant Endocrinologist/Diabetologist at the University Hospitals Birmingham Foundation Trust.

Dr Bates has chosen to maintain a very active, patient focused clinical role since his appointment in 1997. Patient feedback is central in ensuring high quality care. In his last 360 degree appraisal, 25/26 patients were ‘very satisfied’ with their consultation. Comments such as ‘The doctor was excellent and always has been’, ‘ A very competent doctor’, ‘Prepared to listen and give his time’, ‘Friendly and made me feel at ease’ provide strong evidence of high quality care.

Feedback from colleagues is also very relevant. In the same 360 degree appraisal,15/15 colleagues rated Dr Bates as good/outstanding for clinical assessment and 16/16 good/outstanding for patient management. Both scores were above the national/speciality average. Across the whole spectrum of clinical care, 80/80 responses were good/outstanding. Comments such as ‘In my opinion Dr Bates is an outstanding doctor’, ‘Many of his patients I see hold him in very high regard’, ‘Very helpful and supportive..’. are very rewarding.

He regularly attends national and international conferences and has co-authored a total of 55 research abstracts presented to date, including 11 oral presentations.

Read more about Dr Bates at drandrewbates.co.uk.

Consultation fees:

New consultation: £300
Follow-up consultation: £175

Research Highlights

Dr Bates continues to publish research in respected peer-reviewed journals and has an ongoing research interest in the epidemiology of pituitary disease and Addison’s disease. He continues to participate in national and international conferences.

He is a named author in over 20 peer-reviewed publications. These include:

• Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM. (2001) ‘Association between premature mortality and hypopituitarism’ Lancet, 10:357(9254), 425-431
• Sherlock, C. Reulen, A. Aragon Alonso, R., J. Ayuk, R. N. Clayton, M. C. Sheppard, M Hawkins, A. Bates, and P. M. Stewart (2014) ‘A paradigm shift in the monitoring of patients with acromegaly: latest growth hormone overestimates risk’ Journal of Clinical Endocrinology and Metabolism, 99(2), 2013-2450.
• Tahrani AA, Ball A, Shepherd L, Rahim A, Jones AF, Bates A (2010) ‘The prevalence of vitamin D abnormalities in South Asians with type 2 diabetes mellitus in the UK’ International Journal of Clinical Practice, 64(3), 351-5.
• Sherlock, J Ayuk, JW Tomlinson, Toogood AA, A. Aragon-Alonso, M. C. Sheppard, AS. Bates, and P. M. Stewart (2010) ‘Mortality in patients with pituitary disease’ Endocrine Reviews, 31(3), 301-42.

Past presentations include:

• ‘928 biochemical changes with intramuscular testosterone replacement therapy in males with androgen deficiency syndromes-experiences from a large centre in the UK’ at the 18th International Conference of Endocrinology (December 2018)
• ‘What lies beneath? Herbal medications can lead to adrenal insufficiency’ and ‘Impact of ethnicity on the change in total testosterone, haematocrit, and prostate specific antigen with Testosterone Undecanoate treatment’ at the 37th Meeting of the British Endocrine Society (November 2018)

‘The role of an ultrasensitive fourth generation TSH assay in the management of subclinical hyperthyroidism’ at the 19th European Congress of Endocrinology (May 2017)